Skip to Content

Tag: Oral device


Oventus and Aeroflow get first distribution agreement

May 26, 2020HME News Staff

BRISBANE, Australia - Oventus Medical announced May 25 that Aeroflow Healthcare has executed its first subcontract to provide patients of Regional Health Diagnostics with the O2Vent Optima oral treatment for obstructive sleep apnea.“We have been working with Aeroflow for 15 years as the primary CPAP provider for our OSA patients,” said Jeff Ragan, president and CEO of Regional Health Diagnostics, which operates 12 sleep labs across Tennessee, Georgia, Alabama, and North and South Carolina....

Aeroflow, Oral device, Oventus, Sleep Therapy

Read Full Articlered right arrow icon

Also Noted

ProSomnus takes to social media

January 29, 2020HME News Staff

SAN FRANCISCO - ProSomnus Sleep Technologies has launched #ShareYourStory, a social media campaign designed to raise awareness that prescription intraoral devices are a comfortable, effective and recommended alternative to CPAP. “Few are aware that CPAP is no longer the only treatment option for people suffering from sleep breathing issues, such as OSA,” stated ProSomnus, which manufacturers such devices, in a press release. “Covered by most medical insurances and Medicare, the...

Oral device, ProSomnus Sleep Technologies, Sleep Apnea

Read Full Articlered right arrow icon

Also Noted

Oventus ready to hit US market with oral device

September 6, 2019HME News Staff

BRISBANE, Australia - Oventus Medical has received regulatory clearance from the U.S. Food and Drug Administration for its O2Vent Optima oral device to treat obstructive sleep apnea. “We are thrilled to have received FDA clearance, which enables us to sell the O2Vent Optima in the U.S.—a core market for Oventus, alongside Canada and Australia,” said CEO Dr. Chris Hart. “We look forward to officially launching our material agreements within U.S. sleep channels and working with...

FDA, Oral device, Oventus Medical, Sleep Apnea

Read Full Articlered right arrow icon